कोशिश गोल्ड - मुक्त
China is overplaying its hand with its rare-earth choke-offs
Mint Mumbai
|January 12, 2026
Its export curbs aimed at Japan could prove counterproductive
To a hammer, every problem is a nail. If your most potent means of geopolitical leverage is threatening supplies of high-strength magnets, rare-earth elements will always be the solution.
That's the latest approach Beijing is taking in its dispute with Tokyo. Exports of all items with potential military applications to Japan will be immediately banned, China's ministry of commerce said on Tuesday.
The most obvious victim of this threat will be rare-earth magnets made with the elements neodymium and praseodymium, and increasingly spiced up with rarer samarium, dysprosium and terbium. They're used everywhere from charging cables to the switch-gear in wind turbines to motors powering electric vehicles, missile-guidance systems and aircraft flaps.
There's just one problem: Few countries are better prepared against China threatening their rare-earth supplies than Japan. Thanks to similar threats in 2010, it has spent years diversifying its supply chains and building up stockpiles for precisely this sort of eventuality.
While China produces about 80% of the world's neodymium magnets, Japan manufactures about half the remainder, according to UBS SuMi TRUST Wealth Management—levels far above its own roughly 5% share of global manufacturing.
यह कहानी Mint Mumbai के January 12, 2026 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Mint Mumbai से और कहानियाँ
Mint Mumbai
OTTs move past views, eye engagement metrics amid growth slowdown
On a video platform, every click may count as a view.
2 mins
January 13, 2026
Mint Mumbai
The Chinese company taking on the world's memory-chip giants
As AI demand drives prices up, CXMT beats Washington's curbs to vie with Micron and South Korean leaders
4 mins
January 13, 2026
Mint Mumbai
Pak’s conflict with Afghanistan opens $200 mn pharma window for India
Afghanistan’s border tensions with Pakistan, which led to the shutdown of vital transit routes, may have opened up a $200 million pharmaceutical opportunity for India.
2 mins
January 13, 2026
Mint Mumbai
BHEL stock slumps on China fears: Is the sell-off overdone?
Shares of public sector major Bharat Heavy Electricals Ltd (BHEL) have slid nearly 12% over the past three trading sessions, spooking investors after reports suggested a potential policy shift that could reopen India’s power equipment market to Chinese firms.
1 mins
January 13, 2026
Mint Mumbai
WHY VCS HAVE A NEW PLAYBOOK FOR DEEP-TECH
Venture capital has become more accessible while starting up, but is still scarce at the business end
8 mins
January 13, 2026
Mint Mumbai
India at 100: Our choices today will define the next two decades
India's 2047 ambition is not guaranteed but achievable if we address all the potential pitfalls along our development path
4 mins
January 13, 2026
Mint Mumbai
Sukino bets $31 mn in post-hospital care
Venture capital and private equity investors are increasing the bets on post-hospital care-often referred to as 'continuum care' -as hospitals are discharging patients more quickly and families seek structured recovery outside hospitals.
2 mins
January 13, 2026
Mint Mumbai
US productivity is rising and it risks warping monetary policy
America's neutral rate ought to be going up but will the Fed listen?
3 mins
January 13, 2026
Mint Mumbai
Five exercises to bring back into your routine
Try these moves to improve your strength, mobility and cardio health
2 mins
January 13, 2026
Mint Mumbai
Why khichdi, India's comfort food, beats every detox trend
Prepared with lentils and grains, this one-pot meal restores gut balance and offers comfort when the body needs rest most
3 mins
January 13, 2026
Listen
Translate
Change font size
